Lantheus Holdings, Inc. (LNTH) — Fair Value Analysis

Base-case fair value (P50): $126.78 · Current price: $93.06 · Verdict: Undervalued

The Verdict on LNTH

No, LANTHEUS HOLDINGS INC (LNTH) is currently assessed as undervalued based on our Monte Carlo simulations. The model calculates a median fair value (P50) of $126.78, suggesting a substantial +36.2% upside from the current price of $93.06. This valuation indicates that, despite recent market movements, LNTH trades significantly below its probabilistic intrinsic value, presenting a compelling opportunity for investors seeking exposure to the medical imaging sector. Our analysis consistently points to this discount across thousands of forward-looking scenarios.

How LNTH stacks up against peers

LANTHEUS HOLDINGS INC (LNTH) holds an "average" quality tier relative to its sector, reflecting its operational and financial health compared to peers. While this "average" rating provides a baseline understanding of the company's fundamental strength, the Monte Carlo simulation's median fair value of $126.78 still positions the stock with significant upside potential from its $93.06 current price. This gap, a robust +36.2%, suggests that even with average operational metrics, the market may not be fully appreciating LNTH's future cash flow generation capabilities relative to its current valuation.

What this means for investors

The considerable +36.2% gap between LNTH's current price of $93.06 and its median fair value of $126.78 implies a strong undervaluation. While an average quality tier suggests a balanced risk profile relative to its sector, the FairCurve Monte Carlo analysis points to a clear upside scenario. Investors should consider the probabilistic distribution of outcomes, which accounts for various future scenarios beyond just the P50. To explore the full bear and bull case distribution, along with precise probability percentages and to track LNTH's fair value as new fundamentals are released, sign up for a free FairCurve account.